BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16476819)

  • 21. Paralytic ileus in MELAS with phenotypic features of MNGIE.
    Chang TM; Chi CS; Tsai CR; Lee HF; Li MC
    Pediatr Neurol; 2004 Nov; 31(5):374-7. PubMed ID: 15519124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ocular motor disorders in mitochondrial encephalopathy with lactic acid and stroke-like episodes with the 3271 (T-C) point mutation in mitochondrial DNA.
    Shinmei Y; Kase M; Suzuki Y; Nitta T; Chin S; Yoshida K; Goto Y; Nagashima T; Ohno S
    J Neuroophthalmol; 2007 Mar; 27(1):22-8. PubMed ID: 17414868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intestinal pseudo-obstruction in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) associated with phenytoin therapy.
    Chiyonobu T; Noda R; Yoshida M; Fujiki A; Ishii R; Nukina S; Fujita K; Goto Y; Morimoto M
    Brain Dev; 2008 Jun; 30(6):430-3. PubMed ID: 18226864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mitochondrial angiopathy in the cerebral blood vessels of MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and strokelike episodes)].
    Ohama E; Ohara S; Ikuta F; Tanaka K; Nishizawa M; Miyatake T
    No To Shinkei; 1988 Feb; 40(2):109-18. PubMed ID: 3370163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel mtDNA point mutation in tRNA(Val) is associated with hypertrophic cardiomyopathy and MELAS.
    Menotti F; Brega A; Diegoli M; Grasso M; Modena MG; Arbustini E
    Ital Heart J; 2004 Jun; 5(6):460-5. PubMed ID: 15320572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Auditory symptoms: a critical clue for diagnosis of MELAS.
    Tawankanjanachot I; Channarong NS; Phanthumchinda K
    J Med Assoc Thai; 2005 Nov; 88(11):1715-20. PubMed ID: 16471125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated thyroid peroxidase antibodies with encephalopathy in MELAS syndrome.
    Chan DW; Lim CC; Tay SK; Choong CT; Phuah HK
    Pediatr Neurol; 2007 Jun; 36(6):414-7. PubMed ID: 17560506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MELAS syndrome: peripheral neuropathy and cytochrome C-oxidase deficiency: a case report and review of the literature.
    Barak Y; Arnon S; Wolach B; Raz Y; Ashkenasi A; Glick B; Shapira Y
    Isr J Med Sci; 1995 Apr; 31(4):224-9. PubMed ID: 7721560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS).
    Di Trapani G; Gregori B; Servidei S; Ricci E; Sabatelli M; Tonali P
    Clin Neuropathol; 1997; 16(4):195-200. PubMed ID: 9266144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pilot study of mitochondrial DNA point mutation A3243G in a sample of Croatian patients having type 2 diabetes mellitus associated with maternal inheritance.
    Martin-Kleiner I; Pape-Medvidović E; Pavlić-Renar I; Metelko Z; Kusec R; Gabrilovac J; Boranić M
    Acta Diabetol; 2004 Dec; 41(4):179-84. PubMed ID: 15660201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alteration in the copy number of mitochondrial DNA in leukocytes of patients with mitochondrial encephalomyopathies.
    Liu CS; Cheng WL; Lee CF; Ma YS; Lin CY; Huang CC; Wei YH
    Acta Neurol Scand; 2006 May; 113(5):334-41. PubMed ID: 16629770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac tamponade: a new complication in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes.
    Wang W; Seak CJ; Liao SC; Chiu TF; Chen JC
    Am J Emerg Med; 2008 Mar; 26(3):382.e1-2. PubMed ID: 18358970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evolution until death of two members of a family with A3243G mutation and MELAS phenotype versus diabetes mellitus].
    Pérez López-Fraile MI; Barrena R; Montoya J; Marta E
    Neurologia; 2006; 21(6):327-32. PubMed ID: 16799910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Phenotypic variants of A3243G mitochondrial DNA mutation in a Hungarian family].
    Komlósi K; Bene J; Havasi V; Tihanyi M; Herczegfalvi A; Móser J; Melegh B
    Orv Hetil; 2004 Aug; 145(35):1805-9. PubMed ID: 15493224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deep white matter pathologic features in watershed regions: a novel pattern of central nervous system involvement in MELAS.
    Apostolova LG; White M; Moore SA; Davis PH
    Arch Neurol; 2005 Jul; 62(7):1154-6. PubMed ID: 16009776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis and management of MELAS.
    Thambisetty M; Newman NJ
    Expert Rev Mol Diagn; 2004 Sep; 4(5):631-44. PubMed ID: 15347257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nerve conduction abnormalities in patients with MELAS and the A3243G mutation.
    Kaufmann P; Pascual JM; Anziska Y; Gooch CL; Engelstad K; Jhung S; DiMauro S; De Vivo DC
    Arch Neurol; 2006 May; 63(5):746-8. PubMed ID: 16682545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The 3260 mutation in mitochondrial DNA can cause mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS).
    Nishino I; Komatsu M; Kodama S; Horai S; Nonaka I; Goto Y
    Muscle Nerve; 1996 Dec; 19(12):1603-4. PubMed ID: 8941275
    [No Abstract]   [Full Text] [Related]  

  • 39. MELAS masquerading as a systemic vasculitis.
    Carroll MB
    J Clin Rheumatol; 2007 Dec; 13(6):334-7. PubMed ID: 18176143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes: an important cause of stroke in young people.
    Goodfellow JA; Dani K; Stewart W; Santosh C; McLean J; Mulhern S; Razvi S
    Postgrad Med J; 2012 Jun; 88(1040):326-34. PubMed ID: 22328278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.